|
Issue |
Title |
|
Vol 2, No 5 (2016) |
The role of omics in neuroblastoma: Patient’s risk classification and personalised therapy |
Abstract
PDF
|
Maria Rosaria Esposito, Sanja Aveic, Anke Seydel, Gian Paolo Tonini |
|
Vol 3, No 6 (2017) |
The future perspective of PARP inhibitors |
Abstract
PDF
|
Kwong-Kwok Wong |
|
Vol 3, No 5 (2017) |
Advances in pediatric neuro-oncology |
Abstract
PDF
|
Eileen Gillan, Ching C. Lau |
|
Vol 3, No 4 (2017) |
Overview of Hurthle cell carcinoma of thyroid |
Abstract
PDF
|
Martin A Korzeniowski, Aamer Mahmud, Angus Kirby, Kurian Joseph, Evgeny Sadikov, Patricia Tai |
|
Vol 3, No 1 (2017) |
Redefining advances in modern oncology research |
Abstract
PDF
|
Kwong-Kwok Wong |
|
Vol 2, No 6 (2016) |
Immuno-oncology: A changing paradigm in cancer therapy |
Abstract
PDF
|
Omar Abdel-Rahman |
|
1 - 6 of 6 Items |
|